找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Drug Safety and Public Health Policy; A Changing Landscape Charles Bennett,Courtney Lubaczewski,Bartlett With Book 2022 The Editor(s

[復(fù)制鏈接]
查看: 18171|回復(fù): 50
樓主
發(fā)表于 2025-3-21 16:49:00 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Cancer Drug Safety and Public Health Policy
副標(biāo)題A Changing Landscape
編輯Charles Bennett,Courtney Lubaczewski,Bartlett With
視頻videohttp://file.papertrans.cn/222/221097/221097.mp4
概述Analyzes current policy trends regarding cancer drug safety.Explains the policy implications of recent legal settlements.Covers issues in identification and reporting of ADRs
叢書名稱Cancer Treatment and Research
圖書封面Titlebook: Cancer Drug Safety and Public Health Policy; A Changing Landscape Charles Bennett,Courtney Lubaczewski,Bartlett With Book 2022 The Editor(s
描述.This book offers a wide-ranging description and analysis of recent developments and current trends in health policy with regard to cancer drug safety. The book opens with an overview of pharmacovigilance for cancer blockbuster drugs, covering both general considerations and efforts to develop a structured framework for the identification and reporting of adverse drug reactions (ADRs). A number of important examples of serious ADRs to hematology and oncology drugs are then reviewed, with evaluation of the lessons learned and the policy implications of the ensuing legal cases and their settlements. Further, the difficulty of reporting such blockbuster side effects in the medical literature is explored in an empirical study. Significant advances have been achieved in analytic methods for the identification of ADRs, and here there is a particular focus on the value of optimal discriminant analysis. Finally, the impacts on pharmacovigilance and drug safety of the huge fines paid under the U.S. False Claims Act relating to the defrauding of governmental programs also receive careful attention – these fines are playing an important role in changing the landscape for pharmaceutical safety
出版日期Book 2022
關(guān)鍵詞Health Policy; Novel Informatics; Pharmacovigilance; Cancer Drug Safety; Cancer Blockbuster Drogs; Pharma
版次1
doihttps://doi.org/10.1007/978-3-031-04402-1
isbn_softcover978-3-031-04404-5
isbn_ebook978-3-031-04402-1Series ISSN 0927-3042 Series E-ISSN 2509-8497
issn_series 0927-3042
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

書目名稱Cancer Drug Safety and Public Health Policy影響因子(影響力)




書目名稱Cancer Drug Safety and Public Health Policy影響因子(影響力)學(xué)科排名




書目名稱Cancer Drug Safety and Public Health Policy網(wǎng)絡(luò)公開度




書目名稱Cancer Drug Safety and Public Health Policy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cancer Drug Safety and Public Health Policy被引頻次




書目名稱Cancer Drug Safety and Public Health Policy被引頻次學(xué)科排名




書目名稱Cancer Drug Safety and Public Health Policy年度引用




書目名稱Cancer Drug Safety and Public Health Policy年度引用學(xué)科排名




書目名稱Cancer Drug Safety and Public Health Policy讀者反饋




書目名稱Cancer Drug Safety and Public Health Policy讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:47:44 | 只看該作者
Book 2022nalysis. Finally, the impacts on pharmacovigilance and drug safety of the huge fines paid under the U.S. False Claims Act relating to the defrauding of governmental programs also receive careful attention – these fines are playing an important role in changing the landscape for pharmaceutical safety
板凳
發(fā)表于 2025-3-22 03:17:24 | 只看該作者
地板
發(fā)表于 2025-3-22 06:28:11 | 只看該作者
5#
發(fā)表于 2025-3-22 09:18:55 | 只看該作者
6#
發(fā)表于 2025-3-22 16:18:36 | 只看該作者
7#
發(fā)表于 2025-3-22 17:17:44 | 只看該作者
https://doi.org/10.1007/978-3-540-87866-7 Ticlopidine, and Thalidomide from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012;38(08):905–907. .). Prevailing opinion suggests that low reporting rates reflect time constraints.
8#
發(fā)表于 2025-3-22 21:34:33 | 只看該作者
9#
發(fā)表于 2025-3-23 04:00:48 | 只看該作者
10#
發(fā)表于 2025-3-23 07:05:39 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 04:07
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
怀安县| 柳河县| 文昌市| 乐安县| 鄂伦春自治旗| 北流市| 铁岭市| 进贤县| 伊金霍洛旗| 南江县| 潮安县| 涪陵区| 鲁山县| 阳曲县| 溧阳市| 贵定县| 芦溪县| 丰顺县| 南投市| 昌宁县| 桦南县| 遵义县| 佛坪县| 青田县| 罗江县| 瓮安县| 怀柔区| 成安县| 浦城县| 定陶县| 公安县| 平度市| 泽库县| 灵武市| 长治县| 延安市| 陆丰市| 多伦县| 循化| 长治市| 蒙山县|